We are live on ! Find out more
ASMB icon

Assembly Biosciences
ASMB

107 hedge funds and large institutions have $133M invested in Assembly Biosciences in 2021 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 38 increasing their positions, 33 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 33

12% more call options, than puts

Call options by funds: $550K | Put options by funds: $493K

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.58% less ownership

Funds ownership: 6.84% → 6.26% (-0.58%)

6% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 16

2% less funds holding

Funds holding: 109 → 107 (-2)

18% less capital invested

Capital invested by funds: $163M → $133M (-$30.2M)

Holders
107
Holders Change
-2
Holders Change %
-1.83%
% of All Funds
1.88%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
15
Increased
38
Reduced
33
Closed
16
Calls
$550K
Puts
$493K
Net Calls
+$57K
Net Calls Change
-$490K

Top Buyers

1
SCM
Soleus Capital Management
Connecticut
+$6.2M
2
PIM
Platinum Investment Management
Australia
+$3.36M
3
Two Sigma Advisers
Two Sigma Advisers
New York
+$3.2M
4
Two Sigma Investments
Two Sigma Investments
New York
+$3.06M
5
BlackRock
BlackRock
New York
+$2.81M

Top Sellers

1
CCM
Consonance Capital Management
New York
-$11.9M
2
Morgan Stanley
Morgan Stanley
New York
-$2.3M
3
AC
Armistice Capital
New York
-$2.14M
4
SSA
Schonfeld Strategic Advisors
New York
-$1.81M
5
AI
Atom Investors
Texas
-$1.47M
Name Holding Trade Value Shares
Change 		Change in
Stake
N
26
Nuveen
North Carolina
$973K -$6.3K -95 -0.5%
PAM
27
Panagora Asset Management
Massachusetts
$865K +$240K +3,615 +30%
Goldman Sachs
28
Goldman Sachs
New York
$734K +$220K +3,321 +33%
Barclays
29
Barclays
United Kingdom
$703K +$83.8K +1,265 +11%
BCM
30
Bridgeway Capital Management
Texas
$690K +$828K +12,500 New
Connor, Clark & Lunn Investment Management (CC&L)
31
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$638K +$766K +11,562 New
Russell Investments Group
32
Russell Investments Group
United Kingdom
$607K +$722K +10,896 +8,131%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$583K -$1.33K -20 -0.2%
OQS
34
Occudo Quantitative Strategies
Florida
$447K +$257K +3,883 +92%
IA
35
IndexIQ Advisors
New York
$410K +$493K +7,433 New
Millennium Management
36
Millennium Management
New York
$401K +$482K +7,270 New
EGM
37
Engineers Gate Manager
New York
$397K -$199K -3,004 -29%
IC
38
Ikarian Capital
Texas
$334K – – –
Swiss National Bank
39
Swiss National Bank
Switzerland
$324K – – –
UBS AM
40
UBS AM
Illinois
$295K +$93.1K +1,404 +36%
California Public Employees Retirement System
41
California Public Employees Retirement System
California
$287K – – –
CSS
42
Cubist Systematic Strategies
Connecticut
$280K -$360K -5,431 -52%
AA
43
ALPS Advisors
Colorado
$275K +$5.1K +77 +2%
AQR Capital Management
44
AQR Capital Management
Connecticut
$269K -$221K -3,339 -41%
PM
45
Prosight Management
Texas
$260K +$312K +4,708 New
Invesco
46
Invesco
Georgia
$253K +$230K +3,469 +314%
RA
47
Raffles Associates
New York
$230K +$276K +4,167 New
Man Group
48
Man Group
United Kingdom
$229K -$647K -9,761 -70%
Wellington Management Group
49
Wellington Management Group
Massachusetts
$227K -$182K -2,746 -40%
SEI Investments
50
SEI Investments
Pennsylvania
$215K – – –
1
2
3 4 5

ASMB Hedge Fund Activity: Q1 2021 in Review

107 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q1 2021, worth a combined $133M — down 18% from $163M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of ASMB and 15 opened new positions — a net loss of 1 holder — while 33 trimmed existing stakes and 38 added.

The largest buyer was Soleus Capital Management, opening a new position worth an estimated $6.2M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $11.9M sold.

  • 107 institutional investors held Assembly Biosciences (ASMB) as of Q1 2021, down from 109 in Q4 2020.
  • Funds reported $133M of Assembly Biosciences stock for Q1 2021, down 18% quarter-over-quarter.
  • 15 funds opened new Assembly Biosciences positions in Q1 2021 and 16 closed out, a net change of -1 holder.
  • The largest Assembly Biosciences buyer in Q1 2021 was Soleus Capital Management, an estimated $6.2M added.
  • The largest Assembly Biosciences seller in Q1 2021 was Consonance Capital Management, an estimated $11.9M sold.

Based on aggregated 13F filings for Q1 2021.